read the qr report they did mention about vaccine since k1 have class 10k clean room.
page 20
16 COMMENTARY ON PROSPECTS AND TARGETS (Cont’d)

Furthermore, the Group had also adopted specific strategies on top of the above rationales/sales expectations which may help to alleviate overall business for the balance of the year and in the mid-term. In looking ahead, the Group is assessing to develop and/or manufacture medical consumables which are used in conjunction with the COVID-19 vaccine. Simultaneously, the Group is working hard to convert potential US customers to actual clients by riding the foreseeable next wave of manufacturing diversions following the reignited US-China frictions. Multinationals who depended heavily on the Chinese supply chain ecosystem may take steps to re-route their production from China to new locations, including Malaysia as they would take measures to strike a balance between production cost efficiency and risk management.